SCHEMBL6602093

SCHEMBL6602093

COC(=O)N1C=CC=CN1

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
P2RX4 Q99571 1/20 0.32
CHRNB2 P17787 1/20 0.31
CHRNB4 P30926 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA4 P43681 1/20 0.31
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28034490 0.78 USP2 (0.34)
SCHEMBL27571019 0.78 P2RX4 (0.37) P2RX4TSHR
SCHEMBL5195768 0.77
SCHEMBL27336385 0.77
SCHEMBL30754221 0.72
SCHEMBL29570290 0.69 P2RX4 (0.33) P2RX4
SCHEMBL27828912 0.69 TSHR (0.35) TSHR
SCHEMBL7446771 0.68 P2RX4 (0.33) P2RX4
SCHEMBL11662882 0.68
SCHEMBL6464636 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116888126-A Compound of casein kinase inhibitor 北京原基华毅生物科技有限公司 2023-10-13 CN disclosed
CN-111032046-B Pyruvate kinase modulators and uses thereof 安吉奥斯医药品有限公司 2023-09-26 CN disclosed
CN-114302886-A Triazolopyridazine derivative, preparation method, pharmaceutical composition and application thereof 上海赛默罗生物科技有限公司 2022-04-08 CN disclosed
CN-113646050-A Thieno [3,2-B ] pyrrolo [3,2-D ] pyridazinone derivatives and their use as PKM2 derivatives for the treatment of cancer, obesity and diabetes related disorders 安吉奥斯医药品有限公司 2021-11-12 CN disclosed
CN-107635992-B Tricyclic heterocyclic compounds useful as TNF inhibitors 百时美施贵宝公司 2020-05-22 CN disclosed
CN-111032046-A Pyruvate kinase modulators and uses thereof 安吉奥斯医药品有限公司 2020-04-17 CN disclosed
CN-107635992-A Tricyclic heterocyclic compounds useful as TNF inhibitors 百时美施贵宝公司 2018-01-26 CN disclosed
EP-2916842-B1 TRIAZOLO COMPOUNDS HOFFMANN LA ROCHE (CH) 2016-10-19 EP disclosed
EP-2916842-A1 TRIAZOLO COMPOUNDS F. Hoffmann-La Roche AG (CH) 2015-09-16 EP disclosed
CN-102124005-B Cmet inhibitors TAKEDA PHARMACEUTICAL 2014-06-04 CN disclosed
WO-2014072261-A1 TRIAZOLO COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2014-05-15 WO disclosed
CN-102124005-A Cmet inhibitors TAKEDA PHARMACEUTICAL 2011-07-13 CN disclosed
CN-101842098-A Nitrogen-containing bicyclic chemical entities for the treatment of viral infections GENELABS TECH INC 2010-09-22 CN disclosed
EP-1102757-B1 SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES AS HPPAR GAMMA AND HPPAR ALPHA ACTIVATORS GLAXO GROUP LTD (GB) 2004-04-14 EP disclosed
CN-1413112-A Nasal drops containing fused pyridazine derivatives TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-04-23 CN disclosed
US-6498174-B1 AGONISTS TO PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; MODULATING BLOOD GLUCOSE AND LIPID LEVELS; REDUCING DYSLIPIDEMIA AND HYPERINSULINEMIA ASSOCIATED WITH IMPAIRED GLUCOSE TOLERANCE OR METABOLIC SYNDROME SMITHKLINE BEECHAM CORPORATION 2002-12-24 US disclosed
CN-1329614-A Fused pyridazine derivatives, process for preparation of same and uses thereof TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-01-02 CN disclosed
EP-1102757-A1 SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES AS HPPAR GAMMA AND HPPAR ALPHA ACTIVATORS GLAXO GROUP LIMITED (GB) 2001-05-30 EP disclosed
CN-1248259-A Fused pyridazine derivatives, process for producing the same and use thereof TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2000-03-22 CN disclosed
WO-2000008002-A1 SUBSTITUTED OXAZOLES AND THIAZOLES DERIVATIVES AS hPPAR GAMMA AND hPPAR ALPHA ACTIVATORS GLAXO GROUP LIMITED (GB) 2000-02-17 WO disclosed